Paracoccidioidomycosis classification: Difference between revisions

	Paracoccidioidomycosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Paracoccidioidomycosis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Imaging Findings
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Paracoccidioidomycosis classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Paracoccidioidomycosis classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Paracoccidioidomycosis classification
CDC on Paracoccidioidomycosis classification
Paracoccidioidomycosis classification in the news
Blogs on Paracoccidioidomycosis classification
Directions to Hospitals Treating Paracoccidioidomycosis
Risk calculators and risk factors for Paracoccidioidomycosis classification

VisualWikitext

Latest revision as of 20:11, 12 February 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Danitza Lukac

Overview

Paracoccidioidomycosis may be classified based on the onset and duration of symptoms. Paracoccidioidomycosis may be classified into: acute, subacute or chronic. The chronic form can be further subclassified into: unifocal and multifocal.^[1]^[2]

Classification

Latent paracoccidioides infection^[2]^[3]

Patients have no clinical manifestations
Positive reaction to the paracoccidioidin skin test

Paracoccidioides disease

Acute form (Juvenile)
- Usually affects patients under 35 years
Chronic form (Adult)
- Unifocal: Affects one organ or system
- Multifocal: Affects two or more organs or systems

Residual form (Sequela)

Most frequently, chronic pulmonary obstructive disease

References

↑ de Oliveira HC, Assato PA, Marcos CM, Scorzoni L, de Paula E Silva AC, Da Silva Jde F; et al. (2015). "Paracoccidioides-host Interaction: An Overview on Recent Advances in the Paracoccidioidomycosis". Front Microbiol. 6: 1319. doi:10.3389/fmicb.2015.01319. PMC 4658449. PMID 26635779.
↑ ^2.0 ^2.1 Fortes MR, Miot HA, Kurokawa CS, Marques ME, Marques SA (2011). "Immunology of paracoccidioidomycosis". An Bras Dermatol. 86 (3): 516–24. PMID 21738969.
↑ Marques S. Paracoccidiodomicose: atualização epidemiológica, clínica, diagnóstica e terapêutica. An. Bras. Dermatol.2013;88(5):700-711

[pmid26635779-1] Oliveira HC, Assato PA, Marcos CM, Scorzoni L, de Paula E Silva AC, Da Silva Jde F; et al. (2015). "Paracoccidioides-host Interaction: An Overview on Recent Advances in the Paracoccidioidomycosis". Front Microbiol. 6: 1319. doi:10.3389/fmicb.2015.01319. PMC 4658449. PMID 26635779.

[pmid21738969-2] 2.0 ^2.1 Fortes MR, Miot HA, Kurokawa CS, Marques ME, Marques SA (2011). "Immunology of paracoccidioidomycosis". An Bras Dermatol. 86 (3): 516–24. PMID 21738969.

[eee-3] Marques S. Paracoccidiodomicose: atualização epidemiológica, clínica, diagnóstica e terapêutica. An. Bras. Dermatol.2013;88(5):700-711

[1]

[2]

[3]

@@ Line 4: / Line 4: @@
 ==Overview==
-Paracoccidioidomycosis may be classified according to Franco et al. in 1987 into: paracoccidioidomycosis infection, paracoccidioidomycosis disease, paracoccidioidomycosis associated with inmunosupression and residual form (sequela). Based on the duration of symptoms, paracoccidioidomycosis disease may be classified into: acute, subacute or chronic. The chronic form can be subclassified into: unifocal and multifocal.<ref name="pmid26635779">{{cite journal| author=de Oliveira HC, Assato PA, Marcos CM, Scorzoni L, de Paula E Silva AC, Da Silva Jde F et al.| title=Paracoccidioides-host Interaction: An Overview on Recent Advances in the Paracoccidioidomycosis. | journal=Front Microbiol | year= 2015 | volume= 6 | issue=  | pages= 1319 | pmid=26635779 | doi=10.3389/fmicb.2015.01319 | pmc=PMC4658449 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26635779  }} </ref><ref name="pmid21738969">{{cite journal| author=Fortes MR, Miot HA, Kurokawa CS, Marques ME, Marques SA| title=Immunology of paracoccidioidomycosis. | journal=An Bras Dermatol | year= 2011 | volume= 86 | issue= 3 | pages= 516-24 | pmid=21738969 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21738969  }} </ref>
+Paracoccidioidomycosis may be classified based on the onset and duration of symptoms. Paracoccidioidomycosis may be classified into: [[Acute (medical)|acute]], subacute or chronic. The chronic form can be further subclassified into: unifocal and multifocal.<ref name="pmid26635779">{{cite journal| author=de Oliveira HC, Assato PA, Marcos CM, Scorzoni L, de Paula E Silva AC, Da Silva Jde F et al.| title=Paracoccidioides-host Interaction: An Overview on Recent Advances in the Paracoccidioidomycosis. | journal=Front Microbiol | year= 2015 | volume= 6 | issue=  | pages= 1319 | pmid=26635779 | doi=10.3389/fmicb.2015.01319 | pmc=PMC4658449 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26635779  }} </ref><ref name="pmid21738969">{{cite journal| author=Fortes MR, Miot HA, Kurokawa CS, Marques ME, Marques SA| title=Immunology of paracoccidioidomycosis. | journal=An Bras Dermatol | year= 2011 | volume= 86 | issue= 3 | pages= 516-24 | pmid=21738969 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21738969  }} </ref>
 ==Classification==
-*Paracoccidioidomycosis infection
-*Paracoccidioidomycosis disease
+=== '''Latent paracoccidioides infection'''<ref name="pmid21738969">{{cite journal| author=Fortes MR, Miot HA, Kurokawa CS, Marques ME, Marques SA| title=Immunology of paracoccidioidomycosis. | journal=An Bras Dermatol | year= 2011 | volume= 86 | issue= 3 | pages= 516-24 | pmid=21738969 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21738969  }} </ref><ref name="eee">Marques S. Paracoccidiodomicose: atualização epidemiológica, clínica, diagnóstica e terapêutica. ''An. Bras. Dermatol.''2013;88(5):700-711</ref> ===
-**Acute form
+* Patients have no clinical manifestations
-***Moderate
+* Positive reaction to the paracoccidioidin skin test
-***Severe
-**Chronic form
+=== '''Paracoccidioides disease''' ===
-***Unifocal
+*'''Acute form (Juvenile)'''
-****Mild
+**Usually affects patients under 35 years
-****Moderate
+*'''Chronic form (Adult)'''
-****Severe
+**''Unifocal:'' Affects one organ or system
-***Multifocal
+**''Multifocal:'' Affects two or more organs or systems
-****Mild
-****Moderate
+=== '''Residual form''' (Sequela) ===
-****Severe
+*Most frequently, [[Chronic obstructive pulmonary disease|chronic pulmonary obstructive disease]]
-*Paracoccidioidomycosis associated with immunosupresion
-*Residual form (Sequela). <ref name="pmid21738969">{{cite journal| author=Fortes MR, Miot HA, Kurokawa CS, Marques ME, Marques SA| title=Immunology of paracoccidioidomycosis. | journal=An Bras Dermatol | year= 2011 | volume= 86 | issue= 3 | pages= 516-24 | pmid=21738969 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21738969  }} </ref>
 ==References==